| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3120688
Max Phase: Preclinical
Molecular Formula: C28H29FN2O4
Molecular Weight: 476.55
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=c1oc2cc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc2c2c1CCC2
Standard InChI: InChI=1S/C28H29FN2O4/c29-19-6-8-24-26(16-19)35-30-27(24)18-10-13-31(14-11-18)12-1-2-15-33-20-7-9-22-21-4-3-5-23(21)28(32)34-25(22)17-20/h6-9,16-18H,1-5,10-15H2
Standard InChI Key: ONMWMTXOTQHHNU-UHFFFAOYSA-N
Associated Targets(non-human)
Histamine H1 receptor 2054 Activities
Dopamine D3 receptor 1050 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Dopamine D2 receptor 7893 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Serotonin 2a (5-HT2a) receptor 3540 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Serotonin 1a (5-HT1a) receptor 8655 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 476.55 | Molecular Weight (Monoisotopic): 476.2111 | AlogP: 5.60 | #Rotatable Bonds: 7 |
| Polar Surface Area: 68.71 | Molecular Species: BASE | HBA: 6 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 9.14 | CX LogP: 4.82 | CX LogD: 3.08 |
| Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.26 | Np Likeness Score: -1.07 |
References
| 1. Chen Y, Lan Y, Wang S, Zhang H, Xu X, Liu X, Yu M, Liu BF, Zhang G.. (2014) Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics., 74 [PMID:24487191] [10.1016/j.ejmech.2014.01.012] |
Source
Source(1):